Eliquis launch

The whole point of using ZS for all of the layoff periods was to avoid lawsuits...now that tactic places people in areas they have never called on, targeting physicians they have never met, when all it would take is a human element to place people where they should be. I feel for you, former CHR rep.

 

This launch is a grade A cluster fuck....and which RP was in charge of this product, oh yes my ditzy blonde who can't lead her way out of a wet paper bag. Uggggggggggggggggh! Help us!

 

It blows my mind that she is where she is...dancin' and prancin', etc. Seems like she never fails to unimpress in public venues. You'd think Reed and Young would be embarrassed to have her as one of the faces of PC senior mgt! What is the real story behind her rise to power?!

 

PC is going to hit a brick wall next year losing Celebrex and Spiriva. They have known this for some time, since torcetrapib failed and other things fell through. Putting her in there is a creative way to expedite the destruction of this company before it is broken up into separate components. Plus, Jemal Gibson went to Sanofi so we had to take her

 

I was embarrassed at the launch. PFE management in the past was tremendous - Mick Mosebrook &Steere. Now our leadership is a joke (Reed & Deprey) and BMS leadership made us look bad. Noticed BMS stood up to applaud their CEO while we just gave a nice golf clap when our CEO took the stage. that spoke volumes!

 

she's raking in the cash even when her safety blanket AG was shoved to a different post. I hope her reign ends soon, this is unadulterated pain, torture and agony

 

It will all be over in T-minus 11 months. Too bad it has to end with her. It is shocking to see the depths to which we have fallen. BTW, who is that seeing eye dog she always has with her?

 

Yeah, Duprey was painful to watch. The BMS counterpart literally had to take over the remarks. I've never seen anyone in upper mgmt so unprepared. It was like her words and her non verbal communication didn't add up. It was just plain weird.

 

Was Carl "Wood U" Wilbanks in the mix at this launch? Or is he standing on the sidelines this time, enjoying his counterpart look the fool (instead of him)? What about John Young? Was he present, and what kind of impression did he make? I'm guessing he could well be our next CEO. Above remarks about the Pfizer reps response to Ian vs. BMS's reps to their CEO speaks volumes...

 

Young was there. Seems like a stand up guy, but who knows. He did apologize to the field force for all the water they are carrying. He even came to district breakouts to introduce himself. You could tell he felt at home with the field force.

 

Well, two days in the field so far. Folks, we are in trouble. No one, I repeat, no one cares about the data. First, not only do docs thinks they are the same MOA, but they all have the same superiority data. How the fuck do they expect us to scrub that turd when we cant mention the competition? Second, next thing out of their mouths is if it is covered on Part D. Good question since most of their afib patients are OLD! And this is happening with docs we have had relationships with over several years. Imagine what it's gonna look and sound like with the other 2/3 of our territories we've never even set foot in? Fucked up! That's what's it's gone be like.

 

Funny, because the cardiologists I call on are impressed with the data and are 'good-to-go' with prescribing.

 

That's what leadership forgets, " data doesn't sell, relationships do". Sorry, but facts is facts

 

That's what they tell you because you are gullible and they want you to get out of their office. Are you seriously that stupid?

 

Yep, same problem here. No Med D coverage and docs are pushing back on the BID dosing. One doc said that time will prove that the Xa's will all pretty much be the same.

 

Wait until pharmacy starts tracking this potential budget buster and moves to shut it down in CPOEs when it kicks out on dollar variance exception reports.

 

You are right that a re-org prior to launching really messed this up. Local sales management is cleaning up the steaming pile of dog poo that HR and ZS left behind. But in regards to this as a me too- you are wrong. I just interviewed with BI and they are ambivalent to happy that we are bring this out. Pfizer is not competing against BI or J&J or vice versa- we are all going against warfarin. These are new therapies that are being targeted by the biplane chaser 1-800-bad-drug lawyers. Doctors are hesitant to "go out on limb" and write these instead of following the standard or care for the last 3 decades with warfarin. The more of these new anticoagulants that come out, the more they become the new standard of care. The BI guys were int he worst spot coming to market first treating such a fragile class of patients and have paid by now being targeted by the plaintiff lawyers.

 

This is crap. Competitor talking trash.

 

Pfizer rep here not a competitor. Reorg would not have been a big deal if drug was launched in Q2. We would have time to at least feel out new parts of the territory. Reorg a field force and launching a new drug not the best idea.

 

It will be an uphill battle to even get to CPOE when there already is another Xa in the system andon protocols that has more indications, and hospitals will consider them a mee-too class, and Pfizer who will never understand that competitive pricing actually converts into utiliztion.